SCHEMBL3339358

SCHEMBL3339358

Cc1[c]cc2c(c1)cc(C(N)=O)n2C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.39
SLC9A1 P19634 2/20 0.37
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 3/20 0.36
MCL1 Q07820 2/20 0.36
HPGD P15428 2/20 0.36
THRB P10828 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 2/20 0.33
RXFP1 Q9HBX9 2/20 0.33
TP53 P04637 1/20 0.33
DYRK1B Q9Y463 2/20 0.33
AHR P35869 1/20 0.33
GFER P55789 1/20 0.33
CLK1 P49759 1/20 0.33
DYRK1A Q13627 1/20 0.33
GALR3 O60755 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342270 0.81 HSD17B10 (0.36) GPR35ALDH1A1HSD17B10MCL1LMNA
SCHEMBL19345900 0.76 GPR35 (0.47) GPR35SLC9A1KDM4EALDH1A1HSD17B10
SCHEMBL3341263 0.74 SLC9A1 (0.43) GPR35SLC9A1KDM4EALDH1A1HSD17B10
SCHEMBL9613264 0.73 THRB (0.61) KDM4EALDH1A1HSD17B10MCL1HPGD
SCHEMBL3342600 0.71 MCL1 (0.36) MCL1CSNK1A1CLK4
SCHEMBL3339080 0.71 SLC9A1 (0.43) GPR35SLC9A1KDM4EALDH1A1HSD17B10
SCHEMBL6086802 0.70 CLK1 (0.61) GPR35SLC9A1KDM4EALDH1A1HSD17B10
SCHEMBL28238032 0.70 KDM4E (0.60) SLC9A1KDM4EALDH1A1HSD17B10MCL1
SCHEMBL16480591 0.70 PLA2G10 (0.48) GPR35SLC9A1MCL1THRBL3MBTL1
SCHEMBL2323444 0.69 MCL1 (0.71) SLC9A1MCL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393781-B1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-20100160388-A1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160388-A1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS P2RY1, P2RX1, P2RX3 GPR35 270/4885SLC9A1 486/4885KDM4E 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.